Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
1642.0000
8.40
(
0.51
%)
NSE
Jun 06, 2025
15:31 PM
26.07% Fall from 52W High
Volume:
95,999
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
06 Nov 2023, 12:00AM
US FDA Approval
1642.00
0.51%
Slowly getting back on track
Buy:
Gland Pharma Ltd.
by
Motilal Oswal
Target: 1920
Target
Motilal Oswal
Number of FII/FPI investors increased from 193 to 203 in Mar 2025 qtr.
More from Gland Pharma Ltd.
Recommended
Five Interesting Stocks Today - June 06, 2025
The Baseline |
06 Jun 2025, 05:45PM
Market closes higher, RBI’s MPC slashes the Cash Reserve Ratio from 4% to 3%
Trendlyne Marketwatch |
06 Jun 2025, 03:56PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020